|
1
|
Fisher B, Anderson S, Bryant J, Margolese
RG, Deutsch M, Fisher ER, Jeong JH and Wolmark N: Twenty-year
follow-up of a randomized trial comparing total mastectomy,
lumpectomy, and lumpectomy plus irradiation for the treatment of
invasive breast cancer. N Engl J Med. 347:1233–1241. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Early Breast Cancer Trialists'
Collaborative Group (EBCTCG), . Darby S, McGale P, Correa C, Taylor
C, Arriagada R, Clarke M, Cutter D, Davies C, Ewertz M, et al:
Effect of radiotherapy after breast-conserving surgery on 10-year
recurrence and 15-year breast cancer death: Meta-analysis of
individual patient data for 10,801 women in 17 randomised trials.
Lancet. 378:1707–1716. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rudat V, Nour A, Hammoud M and Ghaida SA:
Better compliance with hypofractionation vs. conventional
fractionation in adjuvant breast cancer radiotherapy: Results of a
single, institutional, retrospective study: Results of a single,
institutional, retrospective study. Strahlenther Onkol.
193:375–384. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yarnold J, Ashton A, Bliss J, Homewood J,
Harper C, Hanson J, Haviland J, Bentzen S and Owen R: Fractionation
sensitivity and dose response of late adverse effects in the breast
after radiotherapy for early breast cancer: Long-term results of a
randomised trial. Radiother Oncol. 75:9–17. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
START Trialists' Group, . Bentzen SM,
Agrawal RK, Aird EGA, Barrett JM, Barrett-Lee PJ, Bentzen SM, Bliss
JM, Brown J, Dewar JA, et al: The UK Standardisation of Breast
Radiotherapy (START) Trial B of radiotherapy hypofractionation for
treatment of early breast cancer: A randomised trial. Lancet.
371:1098–1107. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hopwood P, Haviland JS, Sumo G, Mills J,
Bliss JM and Yarnold JR; START Trial Management Group, : Comparison
of patient-reported breast, arm, and shoulder symptoms and body
image after radiotherapy for early breast cancer: 5-year follow-up
in the randomised Standardisation of Breast Radiotherapy (START)
trials. Lancet Oncol. 11:231–240. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Haviland JS, Owen JR, Dewar JA, Agrawal
RK, Barrett J, Barrett-Lee PJ, Dobbs HJ, Hopwood P, Lawton PA,
Magee BJ, et al: The UK standardisation of breast radiotherapy
(START) trials of radiotherapy hypofractionation for treatment of
early breast cancer: 10-year follow-up results of two randomised
controlled trials. Lancet Oncol. 14:1086–1094. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Owen JR, Ashton A, Bliss JM, Homewood J,
Harper C, Hanson J, Haviland J, Bentzen SM and Yarnold JR: Effect
of radiotherapy fraction size on tumour control in patients with
early-stage breast cancer after local tumour excision: Long-term
results of a randomised trial. Lancet Oncol. 7:467–471. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
START Trialists' Group, . Bentzen SM,
Agrawal RK, Aird EGA, Barrett JM, Barrett-Lee PJ, Bliss JM, Brown
J, Dewar JA, Dobbs HJ, et al: The UK Standardisation of Breast
Radiotherapy (START) Trial A of radiotherapy hypofractionation for
treatment of early breast cancer: A randomised trial. Lancet Oncol.
9:331–341. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Attar MA, Bahadur YA, Constantinescu CT
and Eltaher MM: Lung dose analysis in loco-regional
hypofractionated radiotherapy of breast cancer. Saudi Med J.
37:631–637. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Linares I, Tovar MI, Zurita M, Guerrero R,
Expósito M and Del Moral R: Hypofractionated breast radiation:
Shorter scheme, lower toxicity. Clin Breast Cancer. 16:262–268.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Byrd DR, Brookland RK, Washington MK,
Gershenwald JE, Compton CC, Hess KR, Sullivan DC and Jessup JM:
Part XI Breast. AJCC Cancer Staging Manual. Amin MB, Edge SB and
Greene FL: 8th edition. Springer International Publishing;
Heidelberg, Germany: pp. 589–636. 2017
|
|
13
|
U.S. Department of Health and Human
Services, . Common Terminology Criteria for Adverse Events (CTCAE).
Version 5.0. https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/ctcae_v5_quick_reference_5×7.pdfJune
1–2023
|
|
14
|
Petrova D, Smickovska S and Lazarevska E:
Conformity index and homogeneity index of the postoperative whole
breast radiotherapy. Open Access Maced J Med Sci. 5:736–739. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Whelan TJ, Pignol JP, Levine MN, Julian
JA, MacKenzie R, Parpia S, Shelley W, Grimard L, Bowen J, Lukka H,
et al: Long-term results of hypofractionated radiation therapy for
breast cancer. N Engl J Med. 362:513–520. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Offersen BV, Alsner J, Nielsen HM,
Jakobsen EH, Nielsen MH, Krause M, Stenbygaard L, Mjaaland I,
Schreiber A, Kasti UM, et al: Hypofractionated versus standard
fractionated radiotherapy in patients with early breast cancer or
ductal carcinoma in situ in a randomized phase III trial: The DBCG
HYPO trial. J Clin Oncol. 38:3615–3625. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
National Comprehensive Cancer Network
(NCCN). NCCN Guidelines, . Breast Cancer. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1419June
21–2022
|
|
18
|
Smith BD, Bellon JR, Blitzblau R, Freedman
G, Haffty B, Hahn C, Halberg F, Hoffman K, Horst K, Moran J, et al:
Radiation therapy for the whole breast: Executive summary of an
American society for radiation oncology (ASTRO) evidence-based
guideline. Pract Radiat Oncol. 8:145–152. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Krengli M, Sacco M, Loi G, Masini L,
Ferrante D, Gambaro G, Ronco M, Magnani C and Carriero A: Pulmonary
changes after radiotherapy for conservative treatment of breast
cancer: a prospective study. Int J Radiat Oncol Biol Phys.
70:1460–1467. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Verbanck S, Hanon S, Schuermans D, Van
Parijs H, Vinh-Hung V, Miedema G, Verellen D, Storme G, Fontaine C,
Lamote J, et al: Mild lung restriction in breast cancer patients
after hypofractionated and conventional radiation therapy: A 3-year
follow-up. Int J Radiat Oncol Biol Phys. 95:937–945. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hanania AN, Mainwaring W, Ghebre YT,
Hanania NA and Ludwig M: Radiation-induced lung injury: Assessment
and management. Chest. 156:150–162. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mehnati P, Ghorbanipoor M, Mohammadzadeh
M, Motlagh BN and Mesbahi A: Predicting the risk of radiation
pneumonitis and pulmonary function changes after breast cancer
radiotherapy. J Biomed Phys Eng. 11:459–464. 2021.PubMed/NCBI
|
|
23
|
Konkol M, Śniatała P and Milecki P:
Radiation-induced lung injury-what do we know in the era of modern
radiotherapy? Rep Pract Oncol Radiother. 27:552–565.
2022.PubMed/NCBI
|
|
24
|
Marks LB, Bentzen SM, Deasy JO, Kong FMS,
Bradley JD, Vogelius IS, El Naqa I, Hubbs JL, Lebesque JV,
Timmerman RD, et al: Radiation dose-volume effects in the lung. Int
J Radiat Oncol Biol Phys. 76:S70–S76. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
McKenzie E, Razvi Y, Wronski M, Zhang L,
Bosnic S, Vesprini D, Paszat L, Rakovitch E, Drost L, Yee C, et al:
Trends and correlates of mean lung dose in patients receiving
breast radiotherapy in a single institution from 2014 to 2018. Clin
Oncol (R Coll Radiol). 32:647–655. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dicuonzo S, Leonardi MC, Raimondi S,
Corrao G, Bagnardi V, Gerardi MA, Morra A, Zerella MA, Zaffaroni M,
Pansini F, et al: Acute and intermediate toxicity of 3-week
radiotherapy with simultaneous integrated boost using TomoDirect:
Prospective series of 287 early breast cancer patients. Clin Transl
Oncol. 23:1415–1428. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jagsi R, Griffith KA, Moran JM, Matuszak
MM, Marsh R, Grubb M, Abu-Isa E, Dilworth JT, Dominello MM,
Heimburger D, et al: Comparative effectiveness analysis of
3D-conformal radiation therapy versus intensity modulated radiation
therapy (IMRT) in a prospective multicenter cohort of patients with
breast cancer. Int J Radiat Oncol Biol Phys. 112:643–653. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
National Comprehensive Cancer Network
(NCCN). NCCN Guidelines, . Non-Small Cell Lung Cancer. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1450September
26–2022
|
|
29
|
Goldman UB, Wennberg B, Svane G, Bylund H
and Lind P: Reduction of radiation pneumonitis by V20-constraints
in breast cancer. Radiat Oncol. 5:992010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Doi Y, Nakao M, Miura H, Ozawa S, Kenjo M
and Nagata Y: Hybrid volumetric-modulated arc therapy for
postoperative breast cancer including regional lymph nodes: the
advantage of dosimetric data and safety of toxicities. J Radiat
Res. 61:747–754. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lee BM, Chang JS, Kim SY, Keum KC, Suh CO
and Kim YB: Hypofractionated radiotherapy dose scheme and
application of new techniques are associated to a lower incidence
of radiation pneumonitis in breast cancer patients. Front Oncol.
10:1242020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Franceschini D, Fogliata A, Spoto R,
Dominici L, Lo Faro L, Franzese C, Comito T, Lobefalo F, Reggiori
G, Cozzi L, et al: Long term results of a phase II trial of
hypofractionated adjuvant radiotherapy for early-stage breast
cancer with volumetric modulated arc therapy and simultaneous
integrated boost. Radiother Oncol. 164:50–56. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang S, Liao Z, Wei X, Liu HH, Tucker SL,
Hu CS, Mohan R, Cox JD and Komaki R: Analysis of clinical and
dosimetric factors associated with treatment-related pneumonitis
(TRP) in patients with non-small-cell lung cancer (NSCLC) treated
with concurrent chemotherapy and three-dimensional conformal
radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys. 66:1399–1407.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
McKenzie E, Razvi Y, Bosnic S, Wronski M,
Karam I, Vesprini D, Rakovitch E, Soliman H, Wong G and Chow E:
Case series of radiation pneumonitis in breast cancer. J Med
Imaging Radiat Sci. 53:167–174. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Otsuka K, Otsuka M, Itaya T, Matsumoto A,
Sato R, Sagara Y, Oga M and Asayama Y: Risk factors for rectal
bleeding after volumetric-modulated arc radiotherapy of prostate
cancer. Rep Pract Oncol Radiother. 28:15–23. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wu K, Xu X, Li X, Wang J, Zhu L, Chen X,
Wang B, Zhang M, Xia B and Ma S: Radiation pneumonitis in lung
cancer treated with volumetric modulated arc therapy. J Thorac Dis.
10:6531–6539. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Najas GF, Stuart SR, Marta GN, Teixeira
LAB, de Carvalho Gico V, Serante AR, Mauro GP, Lima MC and de
Andrade Carvalho H: Hypofractionated radiotherapy in breast cancer:
A 10-year single institution experience. Rep Pract Oncol Radiother.
26:920–927. 2021. View Article : Google Scholar : PubMed/NCBI
|
